raplixa
mallinckrodt pharmaceuticals ireland limited - humant fibrinogen, human thrombin - hemostase, kirurgisk - antihemorrhagics - støttende behandling, hvor standard kirurgiske teknikker er utilstrækkelige til forbedring af hæmostase. raplixa skal anvendes i kombination med en godkendt gelatine svamp. raplixa er indiceret hos voksne over 18 år.
abboticin 250 mg filmovertrukne tabletter
amdipharm limited - erythromycinstearat - filmovertrukne tabletter - 250 mg
abboticin 500 mg filmovertrukne tabletter
amdipharm limited - erythromycinstearat - filmovertrukne tabletter - 500 mg
abboticin novum 500 mg filmovertrukne tabletter
amdipharm limited - erythromycinethylsuccinat - filmovertrukne tabletter - 500 mg
abboticin novum 500 mg filmovertrukne tabletter
2care4 aps - erythromycinethylsuccinat - filmovertrukne tabletter - 500 mg
lamictal 100 mg tyggetabletter/dispergible tabletter
glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 100 mg
lamictal 200 mg tyggetabletter/dispergible tabletter
glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 200 mg
lamictal 25 mg tyggetabletter/dispergible tabletter
glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 25 mg
lamictal 50 mg tyggetabletter/dispergible tabletter
glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 50 mg
lamictal 5 mg tyggetabletter/dispergible tabletter
glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 5 mg